Trials / Unknown
UnknownNCT00302120
The MONET - Study: MR Mammography of Nonpalpable Breast Tumors
MR Mammography: Randomized Controlled Trial to Study Efficiency of MR Mammography in Reducing the Number of Invasive Interventions in Nonpalpable Suspicious Breast Lesions. The MONET - Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 440 (estimated)
- Sponsor
- UMC Utrecht · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether performing MRI of the breast will improve breast cancer management by reducing the number of biopsies and in case of malignancy allowing one-stage surgical excision of the tumor.
Detailed description
Each year 7000 women present with nonpalpable suspicious breast lesions on mammography in the Netherlands. In the usual care situation, these lesions are detected by mammography and ultrasonography and pathologically characterized by analysis of large core needle biopsy material. In case of malignancy, these lesions are surgically removed. First, a wire is placed in the breast with the tip of the wire within 1 cm of the tumor and then the surgeon follows the wire and removes the lesion. Unfortunately about 25% of women require more that one surgical procedure to remove all tumorous tissue. This is caused by incorrect presurgical diagnosis of the extent and invasiveness of the disease (multifocality, multicentricity, lymph node involvement). We hypothesize that MR mammography will improve presurgical diagnosis and differentiation of lesions and thereby decrease the number of invasive surgical procedures (primary outcome) and number of invasive biopsies (secondary outcome).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Contrast-enhanced MR mammography |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2009-03-01
- Completion
- 2010-03-01
- First posted
- 2006-03-13
- Last updated
- 2008-06-10
Locations
3 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00302120. Inclusion in this directory is not an endorsement.